Prokidney (PROK) Interest Expenses (2021 - 2026)
Prokidney (PROK) posted quarterly Interest Expenses of $13.2 million for Q1 2026, down 0.69% year-over-year from $13.3 million in Q1 2025, and up 119.4% quarter-over-quarter from -$67.8 million in Q4 2025.
Prokidney (PROK) Interest Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Interest Expenses for 6 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 0.69% year-over-year to $13.2 million; the TTM figure through Mar 2026 stood at -$29.8 million (down 160.48% YoY), while the FY2025 annual figure was $42.9 million, up 118.01% from the prior year.
- Interest Expenses advanced to $13.2 million in Q1 2026 per PROK's latest filing, from -$67.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $3.6 billion in Q1 2023 and bottomed at -$67.8 million in Q4 2025.
- Historically, Interest Expenses has averaged $216.5 million across 5 years, with a median of $4.0 million in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses surged 25735614.29% — and 2025, when it sank 444.57%.
- Prokidney's Interest Expenses stood at $2000.0 in 2022, then surged by 2471000.0% to $49.4 million in 2023, then plunged by 60.17% to $19.7 million in 2024, then tumbled by 444.57% to -$67.8 million in 2025, then surged by 119.4% to $13.2 million in 2026.
- Business Quant data shows PROK's Interest Expenses at $13.2 million in Q1 2026, -$67.8 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | 14.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.19 Mn |
| Jun 30, 2026 | 14.19 Mn |
| Mar 31, 2026 | 13.16 Mn |
| Mar 31, 2026 | 13.16 Mn |
| Dec 31, 2025 | -67.83 Mn |
| Dec 31, 2025 | -67.83 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 11.60 Mn |
| Jun 30, 2025 | 11.60 Mn |
| Mar 31, 2025 | 13.25 Mn |
| Mar 31, 2025 | 13.25 Mn |
| Dec 31, 2024 | 19.69 Mn |
| Dec 31, 2024 | 19.69 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Mar 31, 2024 | 4.04 Mn |